Altimmune open to partnerships, deals with drugmakers, says CEO

Weight-loss drug developer Altimmune (ALT.O) is open to deals and collaborations with large drugmakers as it actively looks for partners to launch and develop its experimental obesity drug, CEO Vipin Garg told Reuters on Tuesday. Upbeat mid-stage trial data for its obesity drug and recent…

#vipingarg #upbeat #roche #gaithersburg #maryland #altimmune #garg #novonordisk #cowegovyandozempic #elililly